Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1995 Jan;85(1):83–88. doi: 10.2105/ajph.85.1.83

Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use.

D M Hartel 1, E E Schoenbaum 1, P A Selwyn 1, J Kline 1, K Davenny 1, R S Klein 1, G H Friedland 1
PMCID: PMC1615273  PMID: 7832267

Abstract

OBJECTIVES. The purpose of this study was to examine factors associated with heroin use during methadone maintenance treatment. METHODS. Logistic regression statistical models were used to examine data obtained in a cross-sectional sample of 652 methadone patients. RESULTS. Heroin use during the 3 months prior to interview was shown to be greatest among (1) patients maintained on methadone dosages of less than 70 mg/day (adjusted odds ratio [OR] = 2.1, 95% confidence interval [CI] = 1.3, 3.4) and (2) patients who used cocaine during treatment (adjusted OR = 5.9, 95% CI = 3.8, 9.1). These results were independent of treatment duration, treatment compliance, alcohol use, and socioeconomic factors. Cocaine users were more likely than nonusers of cocaine to use heroin at all methadone dosage levels. CONCLUSIONS. This study confirms and extends past research showing high-dose methadone maintenance to be important to heroin abstinence. Further investigation of the independent association between heroin use and cocaine use is needed.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ball J. C., Lange W. R., Myers C. P., Friedman S. R. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav. 1988 Sep;29(3):214–226. [PubMed] [Google Scholar]
  2. Caplehorn J. R., Bell J., Kleinbaum D. G., Gebski V. J. Methadone dose and heroin use during maintenance treatment. Addiction. 1993 Jan;88(1):119–124. doi: 10.1111/j.1360-0443.1993.tb02769.x. [DOI] [PubMed] [Google Scholar]
  3. Chaisson R. E., Bacchetti P., Osmond D., Brodie B., Sande M. A., Moss A. R. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA. 1989 Jan 27;261(4):561–565. [PubMed] [Google Scholar]
  4. Condelli W. S., Fairbank J. A., Dennis M. L., Rachal J. V. Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. J Subst Abuse Treat. 1991;8(4):203–212. doi: 10.1016/0740-5472(91)90040-h. [DOI] [PubMed] [Google Scholar]
  5. D'Aunno T., Vaughn T. E. Variations in methadone treatment practices. Results from a national study. JAMA. 1992 Jan 8;267(2):253–258. [PubMed] [Google Scholar]
  6. Dole V. P. Implications of methadone maintenance for theories of narcotic addiction. JAMA. 1988 Nov 25;260(20):3025–3029. [PubMed] [Google Scholar]
  7. Dole V. P. Methadone treatment and the acquired immunodeficiency syndrome epidemic. JAMA. 1989 Sep 22;262(12):1681–1682. [PubMed] [Google Scholar]
  8. Dole V. P., Nyswander M. E., Kreek M. J. Narcotic blockade. Arch Intern Med. 1966 Oct;118(4):304–309. [PubMed] [Google Scholar]
  9. Dunteman G. H., Condelli W. S., Fairbank J. A. Predicting cocaine use among methadone patients: analysis of findings from a national study. Hosp Community Psychiatry. 1992 Jun;43(6):608–611. doi: 10.1176/ps.43.6.608. [DOI] [PubMed] [Google Scholar]
  10. Gawin F. H., Ellinwood E. H., Jr Cocaine and other stimulants. Actions, abuse, and treatment. N Engl J Med. 1988 May 5;318(18):1173–1182. doi: 10.1056/NEJM198805053181806. [DOI] [PubMed] [Google Scholar]
  11. Gawin F. H., Kleber H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry. 1986 Feb;43(2):107–113. doi: 10.1001/archpsyc.1986.01800020013003. [DOI] [PubMed] [Google Scholar]
  12. Hubbard R. L., Marsden M. E., Cavanaugh E., Rachal J. V., Ginzburg H. M. Role of drug-abuse treatment in limiting the spread of AIDS. Rev Infect Dis. 1988 Mar-Apr;10(2):377–384. doi: 10.1093/clinids/10.2.377. [DOI] [PubMed] [Google Scholar]
  13. Kosten T. R. Neurobiology of abused drugs. Opioids and stimulants. J Nerv Ment Dis. 1990 Apr;178(4):217–227. doi: 10.1097/00005053-199004000-00001. [DOI] [PubMed] [Google Scholar]
  14. Kreek M. J., Ragunath J., Plevy S., Hamer D., Schneider B., Hartman N. ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans. Neuropeptides. 1984 Dec;5(1-3):277–278. doi: 10.1016/0143-4179(84)90081-7. [DOI] [PubMed] [Google Scholar]
  15. Newman R. G. Advocacy for methadone treatment. Ann Intern Med. 1990 Dec 1;113(11):819–820. doi: 10.7326/0003-4819-113-11-819. [DOI] [PubMed] [Google Scholar]
  16. Novick D. M., Kreek M. J., Fanizza A. M., Yancovitz S. R., Gelb A. M., Stenger R. J. Methadone disposition in patients with chronic liver disease. Clin Pharmacol Ther. 1981 Sep;30(3):353–362. doi: 10.1038/clpt.1981.172. [DOI] [PubMed] [Google Scholar]
  17. Schoenbaum E. E., Hartel D., Selwyn P. A., Klein R. S., Davenny K., Rogers M., Feiner C., Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989 Sep 28;321(13):874–879. doi: 10.1056/NEJM198909283211306. [DOI] [PubMed] [Google Scholar]
  18. Strain E. C., Stitzer M. L., Liebson I. A., Bigelow G. E. Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med. 1993 Jul 1;119(1):23–27. doi: 10.7326/0003-4819-119-1-199307010-00004. [DOI] [PubMed] [Google Scholar]
  19. Strug D. L., Hunt D. E., Goldsmith D. S., Lipton D. S., Spunt B. Patterns of cocaine use among methadone clients. Int J Addict. 1985 Aug;20(8):1163–1175. doi: 10.3109/10826088509056357. [DOI] [PubMed] [Google Scholar]
  20. Tennant F. S., Jr Inadequate plasma concentrations in some high-dose methadone maintenance patients. Am J Psychiatry. 1987 Oct;144(10):1349–1350. doi: 10.1176/ajp.144.10.1349. [DOI] [PubMed] [Google Scholar]
  21. Tennant F., Shannon J. A., Nork J. G., Sagherian A., Berman M. Abnormal adrenal gland metabolism in opioid addicts: implications for clinical treatment. J Psychoactive Drugs. 1991 Apr-Jun;23(2):135–149. doi: 10.1080/02791072.1991.10472232. [DOI] [PubMed] [Google Scholar]
  22. Unterwald E. M., Horne-King J., Kreek M. J. Chronic cocaine alters brain mu opioid receptors. Brain Res. 1992 Jul 3;584(1-2):314–318. doi: 10.1016/0006-8993(92)90912-s. [DOI] [PubMed] [Google Scholar]
  23. Wolff K., Sanderson M., Hay A. W., Raistrick D. Methadone concentrations in plasma and their relationship to drug dosage. Clin Chem. 1991 Feb;37(2):205–209. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES